Management will discuss the company's financial performance and operational highlights starting at 5:00 p.m. Eastern Time. Investors and interested parties can access the live audio stream through the company's website, where an archive of the presentation will remain available for one year. US-based participants may join the call by dialing (800) 836-8184, while international callers should use (646) 357-8785.

Sera Prognostics focuses on precision medicine, specifically through its PreTRM test, which identifies the risk of spontaneous premature delivery in asymptomatic pregnancies. The company currently operates within a sector facing persistent challenges, as noted by recent industry reports highlighting the elevated rates of preterm births in the United States and the associated long-term medical complications for infants.